Friday, September 23, 2016

Pharma Reviews: Pharmaceutical Newsletter - September 19 to 23, 2016

This week saw Lincoln Pharma develop new NDDS formulation in India, Aurobindo Pharma gets tentative approval of Dolutegravir 50mg from USFDA.
Read more: Pharmaceutical Newsletter - September 19 to 23, 2016